Janine Schuurman, Ph.D.

Biotech Consultant at Lust for Life Science

Speaker

Janine’s career centers around the antibody molecule: as a biological source of inspiration and as a therapeutic modality.

For over two decades, she passionately worked to develop innovative antibody therapeutics at Genmab, with her most recent position being Senior Vice President heading Genmab’s Antibody Research and Technologies.

She is a co-inventor of many therapeutic antibodies including FDA-approved therapeutics RYBREVANT^® (amivantamab) and (T)EPKINLY^® (epcoritamab),and of the DuoBody^®, HexaBody^® and HexElect^® technologies, which enable the generation of bispecific and effector-function enhanced antibodies.

She joined The Antibody Society’s Board of Directors in 2020 and currently serves as President of this international, non-profit trade association which represents individuals and organizations involved in antibody-related research and development.

Dr. Schuurman is currently an independent biotech consultant (Lust for Life Science B.V.) and collaborates with many organizations.